ArticleInternational journal of hematology2022
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma.
Rena Shimano et al.PubMed ↗Publisher ↗
No numbers read from the abstract.